At Maks BioSolutions, we operate across strategically focused business lines designed to meet the critical needs of modern healthcare institutions. From plasma-derived therapies to regulatory consulting and logistics coordination, our integrated model supports public health outcomes across the GCC and MENA region.
for primary immune deficiencies, autoimmune, and neurological disorders
for surgical recovery, liver disease, burns, and shock management
To ensure consistent access to life-saving plasma products with excellence in regulatory compliance, product quality, and healthcare logistics.
Please reach out to us regarding your questions or anything.
Answers to common questions about our products, services, and regulatory support across the GCC and MENA regions.
We specialize in Immunoglobulin (IVIG) and Human Albumin (5% and 20%), both essential in critical care, immune deficiencies, liver disease, and surgical recovery.
Yes. All products are SFDA-registered and supplied through NUPCO-approved channels. We ensure full regulatory compliance and documentation with every shipment.
Absolutely. We are experts in regulatory affairs, covering product registration, import licensing, and post-market surveillance for GCC and MENA regions.
We have been supplying plasma products through NUPCO tenders since 2020, making us a trusted and experienced vendor for Saudi Arabia’s central procurement and logistics hub. Our products are pre-approved and regularly delivered under national frameworks.